Literature DB >> 18056363

Leishmania mexicana infection induces impaired lymph node expansion and Th1 cell differentiation despite normal T cell proliferation.

Alice C Hsu1, Phillip Scott.   

Abstract

Leishmania mexicana infections in C57BL/6 mice are associated with minimal immune responses and persistent cutaneous lesions. In contrast, Leishmania major elicits a robust Th1 response that promotes lesion resolution. We investigated whether the nonhealing phenotype associated with L. mexicana was due to a failure of L. mexicana to activate T cells. In vivo T cell responses to infection were assessed by tracking the behavior of labeled naive T cells following the transfer of these cells into congenic mice. Although L. mexicana infection was associated with minimal expansion of the draining lymph nodes, we observed no difference in the percentage of T cells proliferating in response to L. mexicana and L. major. Instead, differences in the size and cellularity of lymph nodes were associated with decreased recruitment of cells trafficking to the lymph node. Furthermore, we found that T cells responding to L. mexicana infection were less able to differentiate into IFN-gamma producing cells, and this deficit extended to previously activated T cells as well. Coadministration of CpG-containing oligodeoxynucleotides at the time of infection overcame this deficit and promoted disease resolution. Taken together, our results identify two distinct components that contribute to the minimal immune response associated with L. mexicana infection. First, despite ample levels of T cell proliferation, L. mexicana fails to induce substantial lymph node expansion, which limits the number of responding T cells. Second, L. mexicana infection fails to drive the differentiation of the majority of responding cells into IFN-gamma producers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056363     DOI: 10.4049/jimmunol.179.12.8200

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated Inflammation.

Authors:  Wook-Jin Chae; Allison K Ehrlich; Pamela Y Chan; Alexandra M Teixeira; Octavian Henegariu; Liming Hao; Jae Hun Shin; Jong-Hyun Park; Wai Ho Tang; Sang-Taek Kim; Stephen E Maher; Karen Goldsmith-Pestana; Peiying Shan; John Hwa; Patty J Lee; Diane S Krause; Carla V Rothlin; Diane McMahon-Pratt; Alfred L M Bothwell
Journal:  Immunity       Date:  2016-02-09       Impact factor: 31.745

2.  Development of an ex vivo lymph node explant model for identification of novel molecules active against Leishmania major.

Authors:  Alex G Peniche; Yaneth Osorio; Adam R Renslo; Doug E Frantz; Peter C Melby; Bruno L Travi
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

3.  Lymph node hypertrophy following Leishmania major infection is dependent on TLR9.

Authors:  Lucas P Carvalho; Patricia M Petritus; Alyssa L Trochtenberg; Colby Zaph; David A Hill; David Artis; Phillip Scott
Journal:  J Immunol       Date:  2011-12-28       Impact factor: 5.422

4.  The magnitude of CD4(+) T-cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice.

Authors:  L Xin; J L Wanderley; Y Wang; D A Vargas-Inchaustegui; L Soong
Journal:  Parasite Immunol       Date:  2011-03       Impact factor: 2.280

5.  Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.

Authors:  Tiago M Castilho; Karen Goldsmith-Pestana; Caterin Lozano; Liliana Valderrama; Nancy G Saravia; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

6.  Rapid Sequestration of Leishmania mexicana by Neutrophils Contributes to the Development of Chronic Lesion.

Authors:  Benjamin P Hurrell; Steffen Schuster; Eva Grün; Manuel Coutaz; Roderick A Williams; Werner Held; Bernard Malissen; Marie Malissen; Shida Yousefi; Hans-Uwe Simon; Andreas J Müller; Fabienne Tacchini-Cottier
Journal:  PLoS Pathog       Date:  2015-05-28       Impact factor: 6.823

Review 7.  Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease.

Authors:  Daniel Feijó; Rafael Tibúrcio; Mariana Ampuero; Cláudia Brodskyn; Natalia Tavares
Journal:  J Immunol Res       Date:  2016-01-19       Impact factor: 4.818

Review 8.  The Biophysics of Lymphatic Transport: Engineering Tools and Immunological Consequences.

Authors:  Meghan J O'Melia; Amanda W Lund; Susan N Thomas
Journal:  iScience       Date:  2019-11-06

9.  Leishmania mexicana induces limited recruitment and activation of monocytes and monocyte-derived dendritic cells early during infection.

Authors:  Patricia M Petritus; Daniel Manzoni-de-Almeida; Ciara Gimblet; Claudia Gonzalez Lombana; Phillip Scott
Journal:  PLoS Negl Trop Dis       Date:  2012-10-18

10.  T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?

Authors:  James Alexander; Frank Brombacher
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.